• locale

  United States

• market

  PRIVATE

• industry

  Biotechnology

• website

  www.oisinbio.com

Oisín Biotechnologies develops therapies using a non-viral delivery technology called Fusogenix™ Proteo-Lipid Vehicle (PLV) for DNA and RNA payloads. This technology enables extensive extrahepatic biodistribution and allows for safe repeated dosing.